Exelixis, Inc. (EX9.DE)
EUR 32.28
(1.22%)
EUR 32.28
(1.22%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.64 USD | 6.67% |
| 2022 | 0.60 USD | -17.81% |
| 2021 | 0.73 USD | 102.78% |
| 2020 | 0.36 USD | -66.04% |
| 2019 | 1.06 USD | -54.31% |
| 2018 | 2.32 USD | 346.15% |
| 2017 | 0.52 USD | 285.71% |
| 2016 | -0.28 USD | 65.43% |
| 2015 | -0.81 USD | 41.3% |
| 2014 | -1.38 USD | -3.76% |
| 2013 | -1.33 USD | -44.57% |
| 2012 | -0.92 USD | -253.33% |
| 2011 | 0.60 USD | 170.59% |
| 2010 | -0.85 USD | 32.54% |
| 2009 | -1.26 USD | 18.18% |
| 2008 | -1.54 USD | -77.01% |
| 2007 | -0.87 USD | 25.64% |
| 2006 | -1.17 USD | -9.35% |
| 2005 | -1.07 USD | 43.39% |
| 2004 | -1.89 USD | -30.34% |
| 2003 | -1.45 USD | 4.61% |
| 2002 | -1.52 USD | 0.65% |
| 2001 | -1.53 USD | 37.04% |
| 2000 | -2.43 USD | -452.27% |
| 1999 | -0.44 USD | 94.42% |
| 1998 | -7.88 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.12 USD | -53.85% |
| 2023 FY | - USD | 6.67% |
| 2023 Q3 | 0.00 USD | -98.72% |
| 2023 Q2 | 0.25 USD | 108.33% |
| 2023 Q1 | 0.12 USD | 228.62% |
| 2023 Q4 | 0.26 USD | 8025.0% |
| 2022 Q4 | -0.09 USD | -140.57% |
| 2022 Q3 | 0.23 USD | 4.55% |
| 2022 Q2 | 0.22 USD | 4.76% |
| 2022 Q1 | 0.21 USD | -30.0% |
| 2022 FY | - USD | -17.81% |
| 2021 FY | - USD | 102.78% |
| 2021 Q3 | 0.12 USD | -61.29% |
| 2021 Q2 | 0.31 USD | 3000.0% |
| 2021 Q1 | 0.01 USD | -88.89% |
| 2021 Q4 | 0.30 USD | 150.0% |
| 2020 Q1 | 0.16 USD | -30.43% |
| 2020 Q2 | 0.22 USD | 37.5% |
| 2020 Q3 | -0.10 USD | -145.45% |
| 2020 Q4 | 0.09 USD | 190.0% |
| 2020 FY | - USD | -66.04% |
| 2019 Q2 | 0.26 USD | 4.0% |
| 2019 FY | - USD | -54.31% |
| 2019 Q4 | 0.23 USD | -28.13% |
| 2019 Q3 | 0.32 USD | 23.08% |
| 2019 Q1 | 0.25 USD | -79.17% |
| 2018 Q1 | 0.39 USD | 200.0% |
| 2018 Q4 | 1.20 USD | 185.71% |
| 2018 FY | - USD | 346.15% |
| 2018 Q2 | 0.29 USD | -25.64% |
| 2018 Q3 | 0.42 USD | 44.83% |
| 2017 Q3 | 0.28 USD | 366.67% |
| 2017 Q2 | 0.06 USD | 0.0% |
| 2017 Q4 | 0.13 USD | -53.57% |
| 2017 FY | - USD | 285.71% |
| 2017 Q1 | 0.06 USD | -50.0% |
| 2016 Q4 | 0.12 USD | 372.73% |
| 2016 Q2 | -0.16 USD | 40.74% |
| 2016 Q1 | -0.27 USD | -42.11% |
| 2016 Q3 | -0.04 USD | 72.5% |
| 2016 FY | - USD | 65.43% |
| 2015 Q3 | -0.22 USD | 0.0% |
| 2015 Q2 | -0.22 USD | -22.22% |
| 2015 Q1 | -0.18 USD | 40.0% |
| 2015 FY | - USD | 41.3% |
| 2015 Q4 | -0.19 USD | 13.64% |
| 2014 FY | - USD | -3.76% |
| 2014 Q4 | -0.30 USD | 6.25% |
| 2014 Q3 | -0.32 USD | 15.79% |
| 2014 Q2 | -0.38 USD | 2.56% |
| 2014 Q1 | -0.39 USD | -2.63% |
| 2013 Q3 | -0.36 USD | -5.88% |
| 2013 Q2 | -0.34 USD | -41.67% |
| 2013 FY | - USD | -44.57% |
| 2013 Q1 | -0.24 USD | 14.29% |
| 2013 Q4 | -0.38 USD | -5.56% |
| 2012 Q4 | -0.28 USD | -40.0% |
| 2012 FY | - USD | -253.33% |
| 2012 Q1 | -0.18 USD | -148.65% |
| 2012 Q2 | -0.25 USD | -38.89% |
| 2012 Q3 | -0.20 USD | 20.0% |
| 2011 FY | - USD | 170.59% |
| 2011 Q1 | -0.24 USD | -50.0% |
| 2011 Q2 | -0.16 USD | 33.33% |
| 2011 Q3 | 0.60 USD | 475.0% |
| 2011 Q4 | 0.37 USD | -38.33% |
| 2010 Q4 | -0.16 USD | -102.02% |
| 2010 Q1 | -0.40 USD | -48.15% |
| 2010 FY | - USD | 32.54% |
| 2010 Q2 | -0.21 USD | 47.5% |
| 2010 Q3 | -0.08 USD | 62.29% |
| 2009 Q1 | -0.34 USD | 5.56% |
| 2009 Q4 | -0.27 USD | -12.5% |
| 2009 Q3 | -0.24 USD | 42.86% |
| 2009 Q2 | -0.42 USD | -23.53% |
| 2009 FY | - USD | 18.18% |
| 2008 Q2 | -0.43 USD | -10.26% |
| 2008 Q1 | -0.39 USD | -95.0% |
| 2008 FY | - USD | -77.01% |
| 2008 Q4 | -0.36 USD | 0.0% |
| 2008 Q3 | -0.36 USD | 16.28% |
| 2007 Q2 | -0.29 USD | -16.0% |
| 2007 Q3 | -0.14 USD | 51.72% |
| 2007 Q1 | -0.25 USD | 13.79% |
| 2007 Q4 | -0.20 USD | -42.86% |
| 2007 FY | - USD | 25.64% |
| 2006 Q2 | -0.29 USD | 9.38% |
| 2006 Q4 | -0.29 USD | 3.33% |
| 2006 Q3 | -0.30 USD | -3.45% |
| 2006 Q1 | -0.32 USD | -3.23% |
| 2006 FY | - USD | -9.35% |
| 2005 Q1 | -0.36 USD | 50.0% |
| 2005 Q4 | -0.31 USD | -6.9% |
| 2005 FY | - USD | 43.39% |
| 2005 Q2 | -0.13 USD | 63.89% |
| 2005 Q3 | -0.29 USD | -123.08% |
| 2004 FY | - USD | -30.34% |
| 2004 Q3 | -0.38 USD | 7.32% |
| 2004 Q4 | -0.72 USD | -89.47% |
| 2004 Q2 | -0.41 USD | -2.5% |
| 2004 Q1 | -0.40 USD | -11.11% |
| 2003 Q4 | -0.36 USD | -2.86% |
| 2003 Q3 | -0.35 USD | 10.26% |
| 2003 Q2 | -0.39 USD | 0.0% |
| 2003 Q1 | -0.39 USD | -5.41% |
| 2003 FY | - USD | 4.61% |
| 2002 FY | - USD | 0.65% |
| 2002 Q4 | -0.37 USD | 9.76% |
| 2002 Q3 | -0.41 USD | 4.65% |
| 2002 Q2 | -0.43 USD | -30.3% |
| 2002 Q1 | -0.33 USD | 15.38% |
| 2001 Q4 | -0.39 USD | -11.43% |
| 2001 FY | - USD | 37.04% |
| 2001 Q2 | -0.52 USD | -79.31% |
| 2001 Q1 | -0.29 USD | -81.25% |
| 2001 Q3 | -0.35 USD | 32.69% |
| 2000 Q3 | -0.22 USD | 31.25% |
| 2000 FY | - USD | -452.27% |
| 2000 Q1 | -1.23 USD | 0.0% |
| 2000 Q2 | -0.32 USD | 73.98% |
| 2000 Q4 | -0.16 USD | 27.27% |
| 1999 FY | - USD | 94.42% |
| 1998 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioNTech SE | 3.87 EUR | 83.463% |
| CureVac N.V. | -1.18 EUR | 154.237% |
| Biotest Aktiengesellschaft | 3.21 EUR | 80.062% |
| Biotest Aktiengesellschaft | 3.21 EUR | 80.062% |
| BRAIN Biotech AG | -0.38 EUR | 268.421% |
| Formycon AG | 4.76 EUR | 86.555% |
| Heidelberg Pharma AG | -0.44 EUR | 245.455% |
| Medigene AG | -0.66 EUR | 196.97% |